文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.

作者信息

Epaulard Olivier, Buisson Marlyse, Nemoz Benjamin, Maréchal Marion Le, Terzi Nicolas, Payen Jean-François, Froidure Marie, Blanc Myriam, Mounayar Anne-Laure, Quénard Fanny, Pierre Isabelle, Pavese Patricia, Germi Raphaele, Grossi Laurence, Larrat Sylvie, Poignard Pascal, Lupo Julien

机构信息

Service des Maladies Infectieuses, Center Hospitalier Universitaire Grenoble-Alpes, Grenoble, France; Groupe de Recherche en Infectiologie Clinique CIC-1406, Inserm - CHUGA - Université Grenoble Alpes, Grenoble, France; UMR 5075 - CEA-CNRS-UGA, Institut de Biologie Structurale, Grenoble, France.

UMR 5075 - CEA-CNRS-UGA, Institut de Biologie Structurale, Grenoble, France; Laboratoire de Virologie, Center Hospitalier Universitaire Grenoble-Alpes, Grenoble, France.

出版信息

J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.009. Epub 2021 Oct 20.

DOI:10.1016/j.jinf.2021.10.009
PMID:34687831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8527702/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64b/8527702/83551896bc66/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64b/8527702/d0cfcb38713e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64b/8527702/83551896bc66/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64b/8527702/d0cfcb38713e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e64b/8527702/83551896bc66/gr2_lrg.jpg

相似文献

[1]
Persistence at one year of neutralizing antibodies after SARS-CoV-2 infection: Influence of initial severity and steroid use.

J Infect. 2022-3

[2]
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.

Microbiol Spectr. 2021-10-31

[3]
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.

Immunity. 2021-8-10

[4]
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays.

Clin Chem. 2020-12-1

[5]
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection.

Front Immunol. 2021

[6]
Neutralizing SARS-CoV-2.

Elife. 2020-12-15

[7]
Persistence of infection-induced SARS-CoV-2 seropositivity throughout gestation.

Am J Obstet Gynecol. 2022-2

[8]
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

Trends Immunol. 2020-4-2

[9]
Characterization of SARS-CoV-2-specific antibodies in COVID-19 patients reveals highly potent neutralizing IgA.

Signal Transduct Target Ther. 2021-1-29

[10]
Neutralizing antibody response elicited by SARS-CoV-2 receptor-binding domain.

Hum Vaccin Immunother. 2021-3-4

引用本文的文献

[1]
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants.

Microbiol Spectr. 2025-1-7

[2]
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.

JCI Insight. 2023-4-24

[3]
A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination.

Viruses. 2022-9-25

[4]
SARS-CoV-2 anti-spike antibodies after a fourth dose of COVID-19 vaccine in adult solid-organ transplant recipients.

Vaccine. 2022-10-19

[5]
Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology.

J Mol Cell Biol. 2022-8-17

[6]
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year.

Front Med (Lausanne). 2022-2-15

[7]
Assessment of Diagnostic Specificity of Anti-SARS-CoV-2 Antibody Tests and Their Application for Monitoring of Seroconversion and Stability of Antiviral Antibody Response in Healthcare Workers in Moscow.

Microorganisms. 2022-2-12

[8]
Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform.

Mol Ther. 2022-5-4

[9]
Humoral immune response to SARS-CoV-2 in five different groups of individuals at different environmental and professional risk of infection.

Sci Rep. 2021-12-30

本文引用的文献

[1]
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans.

Eur J Immunol. 2021-12

[2]
Long-term Persistence of Neutralizing Antibodies to SARS-CoV-2 Following Infection.

J Gen Intern Med. 2021-10

[3]
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers.

N Engl J Med. 2021-10-14

[4]
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis.

Clin Infect Dis. 2022-3-1

[5]
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.

Sci Rep. 2021-7-22

[6]
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.

Front Immunol. 2021

[7]
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.

Clin Microbiol Infect. 2021-10

[8]
Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020-21.

J Infect. 2021-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索